25 May 2013
Keywords: ph, ii, data, pdl, daclizumab, asthma, protein
Article | 22 March 2004
Protein Design Labs of the USA has reported positive results from a Phase II trial evaluating the use of its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 March 2004
15 March 2004
24 May 2013
© 2013 thepharmaletter.com